Nothing to positive here in relation to future business revenue...

Nothing to positive here in relation to future business revenue of any kind:

"As noted in 8.6.1, operating expenses are expected to be lower in early 2023 than
the previous quarter. The Directors continue to review the Company’s costs and expenses
and assess potential sources of revenues and funding including application for research and
development incentive application for 2022. The Company’s current cash balances are
expected to be sufficient to cover the operating expenses in the near future. However, the
Company has a successful history of capital raising and if required the Company will raise
additional capital by one of or a combination of the following: placement of shares, rights
issue, share purchase plan. In addition, the Company also have following funding options
 Potential debt financing of the R&D tax incentive so the Group can receive the money
in advance; and
 Defer certain R&D expenditure to the future to reduce the cash outflows.
The Directors will continue to monitor the ongoing funding requirements of the Company".
Kens